This application generally relates to an apparatus for providing a lead for neuromuscular stimulation that is configured to limit axial forces and tensile load on a distal end of the lead and to reduce movement of the stimulation electrodes.
Many medical devices incorporate an elongated or tubular element that is required to be positioned at a particular anatomical site. Such devices include pacemakers, spinal cord and peripheral nerve stimulators for parathesia systems and functional electrical stimulation, and drug delivery catheters.
In the case of a pacemaker, for example, the leads may be threaded through a vein, and then anchored using a fixation element at the distal tip of the lead to reduce the risk of, or even prevent, dislodgement. Such a fixation element may be a tine, fin, or screw that is secured in the trabeculae or muscle tissue of the ventricle, atrium or cardiac vessel.
Sacral nerve stimulator leads may include a fixation element(s), such as a tine(s), projecting from the lead body to constrain movement of the lead body relative to the surrounding tissue. Tines on a sacral nerve lead, such as the InterStim™ lead available from Medtronic, Inc. of Fridley, Minn., generally are located at a substantial proximal distance from the electrodes and face in only one (proximal) direction. Such placement allows for relative movement of the electrodes as the muscle and connective tissue within which the tines are placed moves relative to the stimulation target.
A spinal cord stimulator (SCS) may include an implantable pulse generator (IPG) connected to one or more leads having one or more electrodes configured to deliver electrical energy to the spinal cord to block pain signals from reaching the brain. Small changes in electrode position may in some cases adversely impact the ability of such systems to effectively deliver therapy. It may not be practical or feasible to provide an anchoring mechanism inside the spinal canal to anchor a lead of the SCS. One conventional technique for securing the lead is to stabilize the lead using a ligature sleeve or suture sleeve secured to the lead body and attached to the superficial fascia with a suture as described, for example, in U.S. Pat. No. 5,957,968 to Belden and U.S. Pat. No. 7,930,039 to Olson. This technique, while commonly used, suffers from drawbacks including significant incidence of lead dislodgement. Another drawback is that the superficial tissue is often at an undesirable distance from the tissue targeted for stimulation. Any change in patient posture which results in a change in the relative distance between the superficial fascia and the stimulation target tissue may result in tension being applied to the lead body and subsequent movement of the electrodes.
U.S. Pat. Nos. 8,428,728 and 8,606,358 to Sachs and U.S. Patent Application Publication No. 2011/0224665 to Crosby et al., all assigned to the assignee of the present invention, and each of which is incorporated herein in their entireties by reference, describe implanted electrical stimulation devices that are designed to restore neural drive and rehabilitate the multifidus muscle to improve stability of the spine. Rather than masking pain signals while the patient's spinal stability potentially undergoes further deterioration, the stimulator systems described in those applications are designed to reactivate the motor control system and/or strengthen the muscles that stabilize the spinal column, which in turn is expected to reduce persistent or recurrent pain. Sachs and Crosby also describe in alternative embodiments peripheral nerve stimulation, in which electrical energy is applied to a nerve to effect a physiological change, such as to elicit a muscle contraction.
While the stimulator systems described in the Sachs patents and Crosby application seek to rehabilitate the multifidus and restore neural drive, use of those systems necessitates the implantation of one or more electrode leads in the vicinity of a predetermined anatomical site, such as the medial branch of the dorsal ramus of the spinal nerve to elicit contraction of the lumbar multifidus muscle. For that application, there is no convenient anatomical structure near the distal end of the lead to allow use of conventional anchoring mechanisms. Anchoring the lead to the superficial fascia as described above initially may be effective in many cases, but leads anchored in this manner may be susceptible to the problems of dislodgement and fatigue-induced fracture.
Previously-known efforts to overcome the problems of lead displacement abound. For example, U.S. Pat. No. 7,493,175 to Cates describes apparatus for subcutaneously anchoring a cardiac electrode lead using multiple tines. Such an apparatus would be undesirable for implantation in or adjacent to spinal muscle as the tines may become dislodged and tear the muscle during movement.
U.S. Pat. No. 7,797,053 to Atkinson describes a tether and a stent like device at the distal portion of a lead that may be expanded inside a cardiac vein to anchor a cardiac pacing lead. A similar stent-like anchor for a neurostimulation lead is described in U.S. Pat. No. 7,917,230 to Bly. U.S. Pat. No. 7,908,015 to Lazeroms describes a stimulation lead to be placed subcutaneously in which the fixation mechanism includes a movable mechanism at the distal end of the lead such that the lead diameter is increased at the distal end when engaged to provide anchoring. U.S. Pat. No. 8,170,690 to Morgan describes use of a helical element (screw) for anchoring a lead. These previously known anchoring systems are ill suited for neuromuscular stimulation because such systems have a high risk of dislodgement of the lead when implanted in or adjacent to muscle.
It therefore would be desirable to provide electrode leads and methods of implantation wherein the lead is securely anchored within a patient and is able to absorb axial movement and tensile load without distributing the load to the distal anchored end, thus reducing the risk of dislodgement of the lead and/or lead fracture.
The present invention overcomes the drawbacks of previously-known systems by providing apparatus for neuromuscular electrical stimulation including an elongated member having a proximal region and a distal region, at least one conductor, and an insulative sheath surrounding at least a portion of the conductor. The elongated member further includes one or more electrodes disposed at the distal region of the elongated member, at least one fixation element disposed at the distal end of the elongated member, so as to secure the one or more electrodes in or adjacent to a desired anatomical site within a patient, and a strain relief portion on the proximal side of the one or more electrodes, so as to reduce transmission of axial loads to the distal region of the elongated member, thereby reducing the risk of fatigue fracture and displacement of the one or more electrodes.
The strain relief portion may be a portion that is elastic and may include a helical coil conductor. The elastic strain relief portion also may include a sheath of insulative material having a lower durometer than the surrounding insulative sheath, thereby allowing the elastic portion to stretch more than the surrounding portions of the elongated member.
The conductor of the elongated member may be a coiled conductor or a cable conductor.
The strain relief portion may include the insulative sheath of the elongated member having a bellowed configuration and the at least one conductor comprising a coiled conductor. The strain relief portion alternatively or additionally may include the elongated member having a sigmoid configuration. The strain relief portion alternatively or additionally may include the elongated member having a helical coiled configuration.
The strain relief portion may include a portion of the elongated member formed in a strain relief loop. The strain relief portion may be contained within a sealed pouch comprising a material which allows fluid ingression but reduces, or preferably prevents, tissue ingrowth.
The elongated member further may comprise a distal tip and a distal connection nut, wherein the first fixation element is moveable between a first insertion position and a second deployed position, and wherein the second deployed position is achieved when at least a portion of the distal tip is coupled to at least a portion of the distal connection nut. A distal tip locking stylet may be included to strengthen the connection between the distal tip and the distal connection nut against axial forces and the distal tip may have an internal aperture for receiving the locking stylet. The locking stylet may be coupled to the distal tip via a plurality of threads that engage with a counterpart plurality of threads on the internal aperture of the distal tip. The locking stylet also may be coupled to the distal tip via at least one engagement member biased radially inward to engage the locking stylet as it is inserted into the internal aperture.
In accordance with another aspect of the present invention, an apparatus for neuromuscular stimulation is provided including an elongated member having a proximal region and a distal region, at least one conductor, and an insulative sheath surrounding at least a portion of the conductor. The elongated member further includes one or more electrodes disposed at the distal region of the elongated member, at least one fixation element disposed at the distal end of the elongated member, so as to secure the one or more electrodes in or adjacent to a desired anatomical site within a patient, and a distal tip and a distal connection nut, wherein a first fixation element of the at least one fixation element is moveable between a first insertion position and a second deployed position, wherein the second deployed position is achieved when at least a portion of the distal tip is coupled to at least a portion of the distal connection nut. The apparatus also may include a distal tip locking stylet to strengthen the connection between the distal tip and the distal connection nut against axial forces, and the distal tip may have an internal aperture for receiving the locking stylet. The locking stylet may be coupled to the distal tip via a plurality of threads that engage with a counterpart plurality of threads on the internal aperture of the distal tip.
The neuromuscular stimulation lead of the present invention comprises a lead body having a strain relief portion and a plurality of electrodes configured to provide electrical stimulation from an implantable pulse generator to neuromuscular tissue located within a patient's back. The leads disclosed herein are particularly adapted for use in stimulating tissue associated with the lumbar spine for use in restoring muscle function and lumbar spine stability, while overcoming lead displacement and fatigue fracture issues observed with previously-known electrode lead designs.
Stimulation Lead with Strain Relief Portion
Referring to
Stimulation lead 10 is a suitable length for positioning electrodes 16 in or adjacent to target tissue while IPG 8 is implanted in a suitable location, e.g., the lower back. For example, stimulation lead 10 may be between about 30 and 80 cm in length, and preferably about 45 or about 65 cm in length. Stimulation lead 10 also has a diameter for placement within the muscles of the lumbar spine, for example, between about 1 and 2 mm in diameter and preferably about 1.3 mm.
Electrodes 16 may be configured to stimulate the tissue at a stimulation frequency and at a level and duration sufficient to cause muscle to contract and may be ring electrodes, partial electrodes, segmented electrodes, nerve cuff electrodes placed around the nerve innervating the target muscle, or the like. Electrodes 16 are a suitable length(s) and spaced apart a suitable distance along stimulation lead 10. For example, electrodes 16 may be about 2-5 mm in length, and preferably about 3 mm, and may be spaced apart about 2-6 mm, and preferably about 4 mm. As will also be understood by one of skill in the art, a stimulation lead may contain more or fewer than the four electrodes shown.
In the embodiment of
The length of and spacing between the fixation elements is defined by the structure around which the fixation elements are to be placed. In one embodiment, the length of each fixation element is between about 1.5-4 mm and preferably about 2.5 mm and the spacing is between about 2 mm and 10 mm and preferably about 6 mm. Proximal and distal fixation elements 19a and 19b are configured to collapse inward toward stimulation lead 10 in a delivery state and to expand in a deployed state. Other fixation elements suitable for use in anchoring stimulation lead 10 of the present invention are described in U.S. Patent Application Pub. No. 2013/0131766 to Crosby and U.S. Patent Application Pub. No. 2013/0338730 to Shiroff, both assigned to the assignee of the present invention, the entire contents of each of which is incorporated herein by reference.
It was observed that during initial clinical testing involving the neuromuscular stimulation of the multifidus muscles of the lumbar spine with IPG 8 and conventional electrode leads, the leads frequently would dislodge and/or fracture after relatively short implantation periods. This was believed to be caused by the lack of suitable anchor sites for the stimulation leads, and also due to the torsional and bending stresses imposed on the stimulation leads by movement of the surrounding muscles. To address these issues, stimulation lead 10 therefore includes strain relief portion 20, which is configured to reduce axial strain on anchoring mechanism 18. In particular, as described below, strain relief portion 20 may take on a variety of structures that are designed to reduce the strain on stimulation lead 10 and anchoring mechanism 18, thereby reducing the risk of lead dislodgement, fatigue fracture, and injury to the tissue through which stimulation lead 10 passes. Each of the embodiments discussed below incorporates a strain relief portion 20, 31, 41, 51, 61, 71, 81 configured to be stretched or extended in response to axial displacements of the proximal part of the lead, and also to accommodate local flexion of, for example, the lumbar spine muscles that may cause localized lateral displacements of the stimulation lead.
Referring now to
Referring to
Referring now to
Similarly,
Deployable Fixation Elements
Additional limitations to the effect of tensile loading on the distal end of a stimulation lead may be provided through additional support mechanisms for maintaining the fixation elements.
As shown in
The present invention provides embodiments for deploying fixation elements actively as shown in
Referring now to
Other locking stylets used for locking the distal tip into the position shown in
Referring now to
Introducer 702 may include introducer lumen 718, distal tip 720, and coupling portion 722. Introducer lumen 718 extends through introducer 702 and is shaped and sized to permit electrode lead 200 to slide therethrough. Distal tip 720 is beveled to ease introduction through tissue. Coupling portion 722, illustratively a female end with threads, is configured to be coupled to a portion of dilator 704. In one embodiment, introducer 702 comprises a commercially available 7 French (Fr) introducer.
Dilator 704 may include dilator lumen 724, distal tip 726, coupling portion 728, and handle 730. Dilator lumen 724 extends through dilator 704 and is shaped and sized to permit introducer 702 to slide therethrough. Distal tip 726 is beveled to ease introduction through tissue. Coupling portion 728, illustratively a male end with threads, is configured to be coupled to a portion of introducer 702, e.g., coupling portion 722. Handle 730 is sized and shaped to permit a physician to comfortably hold dilator 704.
Next, a stylet is inserted within the stylet lumen of electrode lead 200 to provide additional stiffness to electrode lead 200 to ease passage of electrode lead 200 through introducer 702. The stylet may be a commercially available stylet such as a locking stylet available from Cook Group Incorporated of Bloomington, Ind. Electrode lead 200 then is inserted within introducer lumen 718 of introducer 702.
Using fluoroscopy, acoustic, anatomic, or CT guidance, dilator 704 is delivered transcutaneously and transmuscularly to a target site, e.g., in or adjacent to tissue associated with control of the lumbar spine. Such tissue may include nervous tissue, muscle, ligament, and/or joint capsule. In one embodiment, muscle includes skeletal muscle such as the multifidus, transverse abdominus, quadratus lumborum, psoas major, internus abdominus, obliquus externus abdominus, and erector spinae muscles and nervous tissue includes a peripheral nerve that innervates skeletal muscle. In a preferred embodiment, nervous tissue comprises the dorsal ramus nerve, or fascicles thereof, that innervate the multifidus muscle.
Next, introducer 702 (having a portion of the electrode lead disposed therein) is inserted through dilator lumen 724 to the target site. Introducer 702 may then be coupled to dilator 704, e.g., by screwing coupling portion 722 onto coupling portion 728.
A segment of a typical human lumbar spine shown has a vertebral body V, transverse process TP, inter-transverse ligament ITL, and a dorsal ramus DR. Dilator 704 having introducer 702 disposed therethrough, which has a portion of the electrode lead disposed therein, are positioned adjacent to the target site, the medial branch of the dorsal ramus DR nerve that innervates the multifidus muscle. In one embodiment, electrodes of the electrode lead are positioned to stimulate the medial branch of the dorsal ramus that exits between the L2 and L3 lumbar segments and passes over the transverse process of the L3 vertebra, thereby eliciting contraction of fascicles of the lumbar multifidus at the L3, L4, L5 and Si segments and in some patients also at the L2 segment.
Introducer 702 and dilator 704 are moved proximally, e.g., using handle 730, while maintaining the position of electrode lead 200 at the target site. The first and second fixation elements of electrode lead 200 individually transition from a collapsed state within introducer 702 to an expanded state, as introducer 702 passes over the respective fixation element. The first and second fixation elements sandwich an anchor site, e.g., muscle, therebetween without damaging the anchor site in the expanded state to fix electrode lead 200 at the target site.
Introducer 702 and dilator 704 are moved proximally off the proximal end of electrode lead 200 and suture sleeve 700 is placed over the proximal end of electrode lead 200 and moved distally. When suture sleeve 700 is positioned adjacent to the superficial fascia SF beneath skin SK, sutures are sewn into the first and second grooves of suture sleeve 700 so as to secure suture sleeve 700 to the superficial fascia SF.
Finally, the IPG is coupled to the proximal end of electrode lead 200 and implanted within the lower back of the patient.
While various illustrative embodiments of the invention are described above, it will be apparent to one skilled in the art that various changes and modifications may be made therein without departing from the invention. The appended claims are intended to cover all such changes and modifications that fall within the true scope of the invention.
This application is a continuation-in-part application of U.S. patent application Ser. No. 14/061,614, filed Oct. 23, 2013, the entire contents of which is incorporated herein by reference. This application is also a continuation-in-part application of U.S. patent application Ser. No. 13/797,100, filed Mar. 12, 2013, which claims the benefit of priority of U.S. Provisional Application Ser. No. 61/659,334, filed Jun. 13, 2012, the entire contents of each of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3077884 | Bartow et al. | Feb 1963 | A |
3416534 | Quinn | Dec 1968 | A |
3710777 | Sparks | Jan 1973 | A |
3754555 | Schmitt | Aug 1973 | A |
3875947 | Jula et al. | Apr 1975 | A |
3893463 | Williams | Jul 1975 | A |
3902501 | Citron et al. | Sep 1975 | A |
3976082 | Schmitt | Aug 1976 | A |
3999551 | Spitz et al. | Dec 1976 | A |
4010757 | Jula et al. | Mar 1977 | A |
4026301 | Friedman et al. | May 1977 | A |
4031899 | Renirie | Jun 1977 | A |
4149528 | Murphy | Apr 1979 | A |
4235246 | Weiss | Nov 1980 | A |
4269198 | Stokes | May 1981 | A |
4342317 | Axelgaard | Aug 1982 | A |
4408609 | Axelgaard | Oct 1983 | A |
4418693 | Leveen et al. | Dec 1983 | A |
4528984 | Morawetz et al. | Jul 1985 | A |
4549556 | Tarjan et al. | Oct 1985 | A |
4574806 | McCarthy | Mar 1986 | A |
4658835 | Pohndorf | Apr 1987 | A |
4832687 | Smith, III | May 1989 | A |
4917093 | Dufresne et al. | Apr 1990 | A |
5069680 | Grandjean | Dec 1991 | A |
5199430 | Fang et al. | Apr 1993 | A |
5215088 | Normann et al. | Jun 1993 | A |
5273053 | Pohndorf | Dec 1993 | A |
5300108 | Rebell | Apr 1994 | A |
5330515 | Rutecki et al. | Jul 1994 | A |
5376108 | Collins | Dec 1994 | A |
5496345 | Kieturakis et al. | Mar 1996 | A |
5501452 | Halvorson | Mar 1996 | A |
5507788 | Lieber | Apr 1996 | A |
5522854 | Ideker et al. | Jun 1996 | A |
5569183 | Kieturakis | Oct 1996 | A |
5638825 | Yamazaki et al. | Jun 1997 | A |
5733307 | Dinsdale | Mar 1998 | A |
5741321 | Brennen | Apr 1998 | A |
5782841 | Ritz et al. | Jul 1998 | A |
5807234 | Bui et al. | Sep 1998 | A |
5873900 | Maurer et al. | Feb 1999 | A |
5916172 | Hodges et al. | Jun 1999 | A |
5957968 | Belden et al. | Sep 1999 | A |
6104957 | Alo et al. | Aug 2000 | A |
6119516 | Hock | Sep 2000 | A |
6314325 | Fitz | Nov 2001 | B1 |
6319241 | King et al. | Nov 2001 | B1 |
6324414 | Gibbons et al. | Nov 2001 | B1 |
6366819 | Stokes | Apr 2002 | B1 |
6381496 | Meadows et al. | Apr 2002 | B1 |
6406421 | Grandjean et al. | Jun 2002 | B1 |
6473654 | Chinn | Oct 2002 | B1 |
6516227 | Meadows et al. | Feb 2003 | B1 |
6527787 | Fogarty et al. | Mar 2003 | B1 |
6565594 | Herweck et al. | May 2003 | B1 |
6600954 | Cohen et al. | Jul 2003 | B2 |
6600956 | Maschino et al. | Jul 2003 | B2 |
6605094 | Mann et al. | Aug 2003 | B1 |
6671557 | Gliner | Dec 2003 | B1 |
6735474 | Loeb et al. | May 2004 | B1 |
6839594 | Cohen et al. | Jan 2005 | B2 |
6845271 | Fang et al. | Jan 2005 | B2 |
6862479 | Whitehurst et al. | Mar 2005 | B1 |
7018384 | Skakoon | Mar 2006 | B2 |
7096070 | Jenkins et al. | Aug 2006 | B1 |
7206641 | Ignagni et al. | Apr 2007 | B2 |
7218970 | Ley et al. | May 2007 | B2 |
7239918 | Strother et al. | Jul 2007 | B2 |
7286879 | Wallace | Oct 2007 | B2 |
7317948 | King et al. | Jan 2008 | B1 |
7324852 | Barolat et al. | Jan 2008 | B2 |
7324853 | Ayal et al. | Jan 2008 | B2 |
7337005 | Kim et al. | Feb 2008 | B2 |
7337006 | Kim et al. | Feb 2008 | B2 |
7369894 | Gerber | May 2008 | B2 |
7389149 | Rossing | Jun 2008 | B2 |
7444181 | Shi et al. | Oct 2008 | B2 |
7447546 | Kim et al. | Nov 2008 | B2 |
7450993 | Kim et al. | Nov 2008 | B2 |
7489561 | Armstrong et al. | Feb 2009 | B2 |
7493175 | Cates et al. | Feb 2009 | B2 |
7499746 | Buhlmann et al. | Mar 2009 | B2 |
7502651 | Kim et al. | Mar 2009 | B2 |
7580753 | Kim et al. | Aug 2009 | B2 |
7668598 | Herregraven et al. | Feb 2010 | B2 |
7684866 | Fowler et al. | Mar 2010 | B2 |
7708763 | Selover et al. | May 2010 | B2 |
7761166 | Giftakis et al. | Jul 2010 | B2 |
7792591 | Rooney et al. | Sep 2010 | B2 |
7797053 | Atkinson et al. | Sep 2010 | B2 |
7813803 | Heruth et al. | Oct 2010 | B2 |
7908015 | Lazeroms et al. | Mar 2011 | B2 |
7917230 | Bly | Mar 2011 | B2 |
7930039 | Olson | Apr 2011 | B2 |
7981144 | Geist et al. | Jul 2011 | B2 |
8016846 | McFarlin et al. | Sep 2011 | B2 |
8065020 | Ley et al. | Nov 2011 | B2 |
8082039 | Kim et al. | Dec 2011 | B2 |
8170690 | Morgan et al. | May 2012 | B2 |
8229565 | Kim et al. | Jul 2012 | B2 |
8229656 | Ikushima et al. | Jul 2012 | B2 |
8249701 | Imran et al. | Aug 2012 | B2 |
8249713 | Fang et al. | Aug 2012 | B2 |
8380318 | Kishawi et al. | Feb 2013 | B2 |
8391966 | Luo et al. | Mar 2013 | B2 |
8409233 | Chinn et al. | Apr 2013 | B1 |
8428728 | Sachs | Apr 2013 | B2 |
8463383 | Sakai et al. | Jun 2013 | B2 |
8498697 | Yong et al. | Jul 2013 | B2 |
8606358 | Sachs | Dec 2013 | B2 |
8798005 | Vargantwar et al. | Aug 2014 | B1 |
8886337 | Bennett et al. | Nov 2014 | B2 |
8965516 | Bennett et al. | Feb 2015 | B2 |
9072897 | Sachs et al. | Jul 2015 | B2 |
9079019 | Crosby et al. | Jul 2015 | B2 |
9108053 | Crosby et al. | Aug 2015 | B2 |
9320847 | Rooney et al. | Apr 2016 | B2 |
9561364 | Bondhus | Feb 2017 | B2 |
9861811 | Crosby et al. | Jan 2018 | B2 |
20010053885 | Gielen et al. | Dec 2001 | A1 |
20020065543 | Gomperz | May 2002 | A1 |
20020099419 | Cohen et al. | Jul 2002 | A1 |
20020115945 | Herman et al. | Aug 2002 | A1 |
20020147485 | Mamo et al. | Oct 2002 | A1 |
20020156513 | Borkan | Oct 2002 | A1 |
20020161415 | Cohen et al. | Oct 2002 | A1 |
20020183765 | Adams | Dec 2002 | A1 |
20030100933 | Ayal et al. | May 2003 | A1 |
20030120328 | Jenkins et al. | Jun 2003 | A1 |
20030199938 | Smits et al. | Oct 2003 | A1 |
20040030360 | Eini et al. | Feb 2004 | A1 |
20040097986 | Adams | May 2004 | A1 |
20040111118 | Hill et al. | Jun 2004 | A1 |
20040122482 | Tung et al. | Jun 2004 | A1 |
20040147969 | Mann et al. | Jul 2004 | A1 |
20040167580 | Mann et al. | Aug 2004 | A1 |
20040214790 | Borgens | Oct 2004 | A1 |
20040230281 | Heil | Nov 2004 | A1 |
20040236383 | Yelizarov | Nov 2004 | A1 |
20050070971 | Fowler et al. | Mar 2005 | A1 |
20050075701 | Shafer | Apr 2005 | A1 |
20050080472 | Atkinson et al. | Apr 2005 | A1 |
20050107861 | Harris et al. | May 2005 | A1 |
20050119713 | Whitehurst et al. | Jun 2005 | A1 |
20050149154 | Cohen et al. | Jul 2005 | A1 |
20050154389 | Selover et al. | Jul 2005 | A1 |
20050165456 | Mann et al. | Jul 2005 | A1 |
20050177211 | Leung et al. | Aug 2005 | A1 |
20050240243 | Barolat et al. | Oct 2005 | A1 |
20050246006 | Daniels | Nov 2005 | A1 |
20050283204 | Buhlmann et al. | Dec 2005 | A1 |
20060004429 | Mrva et al. | Jan 2006 | A1 |
20060009810 | Mann et al. | Jan 2006 | A1 |
20060009827 | Kurth et al. | Jan 2006 | A1 |
20060032657 | Zarembo | Feb 2006 | A1 |
20060052856 | Kim et al. | Mar 2006 | A1 |
20060106416 | Raymond et al. | May 2006 | A1 |
20060111746 | Foreman et al. | May 2006 | A1 |
20060111754 | Rezai et al. | May 2006 | A1 |
20060155341 | Tehrani et al. | Jul 2006 | A1 |
20060184222 | Camps et al. | Aug 2006 | A1 |
20060206166 | Weiner | Sep 2006 | A1 |
20060235484 | Jaax et al. | Oct 2006 | A1 |
20060241716 | Finch et al. | Oct 2006 | A1 |
20060259074 | Kelleher et al. | Nov 2006 | A1 |
20070027501 | Jensen et al. | Feb 2007 | A1 |
20070049980 | Zielinski | Mar 2007 | A1 |
20070060967 | Strother et al. | Mar 2007 | A1 |
20070073357 | Rooney et al. | Mar 2007 | A1 |
20070100377 | Armstrong et al. | May 2007 | A1 |
20070100391 | Armstrong | May 2007 | A1 |
20070100408 | Gerber | May 2007 | A1 |
20070100411 | Bonde | May 2007 | A1 |
20070123954 | Gielen et al. | May 2007 | A1 |
20070129780 | Whitehurst et al. | Jun 2007 | A1 |
20070135768 | Carlsen | Jun 2007 | A1 |
20070179557 | Maschino et al. | Aug 2007 | A1 |
20070208392 | Kuschner et al. | Sep 2007 | A1 |
20070232936 | Mann et al. | Oct 2007 | A1 |
20070239224 | Bennett et al. | Oct 2007 | A1 |
20080026981 | Muhrer et al. | Jan 2008 | A1 |
20080103573 | Gerber | May 2008 | A1 |
20080103579 | Gerber | May 2008 | A1 |
20080132961 | Jaax et al. | Jun 2008 | A1 |
20080132969 | Bennett et al. | Jun 2008 | A1 |
20080167698 | Kim et al. | Jul 2008 | A1 |
20080177351 | Fang et al. | Jul 2008 | A1 |
20080183221 | Burdulis | Jul 2008 | A1 |
20080183257 | Imran et al. | Jul 2008 | A1 |
20080200972 | Rittman et al. | Aug 2008 | A1 |
20080228241 | Sachs | Sep 2008 | A1 |
20080234791 | Arle et al. | Sep 2008 | A1 |
20080269716 | Bonde et al. | Oct 2008 | A1 |
20080269812 | Gerber et al. | Oct 2008 | A1 |
20090005833 | Cameron et al. | Jan 2009 | A1 |
20090018576 | Binmoeller | Jan 2009 | A1 |
20090020764 | Anderson et al. | Jan 2009 | A1 |
20090112263 | Pool et al. | Apr 2009 | A1 |
20090192567 | Armstrong et al. | Jul 2009 | A1 |
20090210041 | Kim et al. | Aug 2009 | A1 |
20090248095 | Schleicher | Oct 2009 | A1 |
20090254095 | Levine et al. | Oct 2009 | A1 |
20090259280 | Wilkin et al. | Oct 2009 | A1 |
20090299201 | Gunderson | Dec 2009 | A1 |
20090326613 | Knoblich | Dec 2009 | A1 |
20100030227 | Kast et al. | Feb 2010 | A1 |
20100036280 | Ballegaard et al. | Feb 2010 | A1 |
20100036454 | Bennett et al. | Feb 2010 | A1 |
20100082086 | Zhu | Apr 2010 | A1 |
20100114206 | Kaemmerer et al. | May 2010 | A1 |
20100137938 | Kishawi et al. | Jun 2010 | A1 |
20100152808 | Boggs, II | Jun 2010 | A1 |
20100152809 | Boggs, II | Jun 2010 | A1 |
20100174240 | Wells et al. | Jul 2010 | A1 |
20100174326 | Selover et al. | Jul 2010 | A1 |
20100179562 | Linker et al. | Jul 2010 | A1 |
20100185161 | Pellegrino et al. | Jul 2010 | A1 |
20100211149 | Morgan et al. | Aug 2010 | A1 |
20100249875 | Kishawi et al. | Sep 2010 | A1 |
20100280576 | Gerber et al. | Nov 2010 | A1 |
20100292769 | Brounstein et al. | Nov 2010 | A1 |
20110004269 | Strother et al. | Jan 2011 | A1 |
20110021943 | Lacour et al. | Jan 2011 | A1 |
20110022114 | Navarro | Jan 2011 | A1 |
20110022123 | Stancer et al. | Jan 2011 | A1 |
20110054565 | Wacnik et al. | Mar 2011 | A1 |
20110106207 | Cauller et al. | May 2011 | A1 |
20110160538 | Ravikumar et al. | Jun 2011 | A1 |
20110190786 | Gerber et al. | Aug 2011 | A1 |
20110224665 | Crosby et al. | Sep 2011 | A1 |
20110224682 | Westlund et al. | Sep 2011 | A1 |
20110251662 | Griswold et al. | Oct 2011 | A1 |
20110257660 | Jones et al. | Oct 2011 | A1 |
20110270340 | Pellegrini et al. | Nov 2011 | A1 |
20120035953 | Armstrong | Feb 2012 | A1 |
20120089153 | Christopherson et al. | Apr 2012 | A1 |
20120116477 | Crowe et al. | May 2012 | A1 |
20120192874 | Bolea et al. | Aug 2012 | A1 |
20120215218 | Lipani | Aug 2012 | A1 |
20120283800 | Perryman et al. | Nov 2012 | A1 |
20120290055 | Boggs, II | Nov 2012 | A1 |
20120310140 | Kramer et al. | Dec 2012 | A1 |
20120310301 | Bennett et al. | Dec 2012 | A1 |
20120310302 | Bennett et al. | Dec 2012 | A1 |
20120310314 | Bennett et al. | Dec 2012 | A1 |
20120323253 | Garai et al. | Dec 2012 | A1 |
20130023974 | Amrani | Jan 2013 | A1 |
20130053926 | Hincapie Ordonez et al. | Feb 2013 | A1 |
20130096641 | Strother et al. | Apr 2013 | A1 |
20130131766 | Crosby et al. | May 2013 | A1 |
20130155117 | Bang | Jun 2013 | A1 |
20130197607 | Wilder et al. | Aug 2013 | A1 |
20130197615 | Rundle et al. | Aug 2013 | A1 |
20130211487 | Fang et al. | Aug 2013 | A1 |
20130218247 | Sachs | Aug 2013 | A1 |
20130238066 | Boggs et al. | Sep 2013 | A1 |
20130245715 | Peterson | Sep 2013 | A1 |
20130261696 | Thacker et al. | Oct 2013 | A1 |
20130296966 | Wongsarnpigoon et al. | Nov 2013 | A1 |
20130310901 | Perryman et al. | Nov 2013 | A1 |
20130338730 | Shiroff et al. | Dec 2013 | A1 |
20140039574 | Bradley | Feb 2014 | A1 |
20140046398 | Sachs et al. | Feb 2014 | A1 |
20140058476 | Crosby et al. | Feb 2014 | A1 |
20140114385 | Nijhuis et al. | Apr 2014 | A1 |
20140288616 | Rawat et al. | Sep 2014 | A1 |
20150105840 | Boggs, II | Apr 2015 | A1 |
20150306405 | Sachs et al. | Oct 2015 | A1 |
20150374992 | Crosby et al. | Dec 2015 | A1 |
20160045746 | Jiang et al. | Feb 2016 | A1 |
20160045747 | Jiang et al. | Feb 2016 | A1 |
20160067476 | Rawat et al. | Mar 2016 | A1 |
20160106994 | Crosby et al. | Apr 2016 | A1 |
20160213927 | McGee et al. | Jul 2016 | A1 |
Number | Date | Country |
---|---|---|
1211930 | Jul 2005 | CN |
101678203 | Mar 2010 | CN |
0 587 269 | Dec 1998 | EP |
1 053 762 | Nov 2000 | EP |
1 255 583 | Nov 2002 | EP |
2 125 100 | Dec 2009 | EP |
2 273 931 | Jan 2011 | EP |
WO-0158520 | Aug 2001 | WO |
WO-2004066820 | Aug 2004 | WO |
WO-2006091611 | Aug 2006 | WO |
WO-2006133445 | Dec 2006 | WO |
WO-2006135791 | Dec 2006 | WO |
WO-2007051146 | May 2007 | WO |
WO-2007138598 | Dec 2007 | WO |
WO-2008048471 | Apr 2008 | WO |
WO-2008070807 | Jun 2008 | WO |
WO-2008094952 | Aug 2008 | WO |
WO-2008112178 | Sep 2008 | WO |
WO-2009020764 | Feb 2009 | WO |
WO-2009134475 | Nov 2009 | WO |
WO-2010062600 | Jun 2010 | WO |
WO-2010062622 | Jun 2010 | WO |
WO-2011079866 | Jul 2011 | WO |
WO-2011112773 | Sep 2011 | WO |
WO-2012057916 | May 2012 | WO |
WO-2012091747 | Jul 2012 | WO |
WO-2013016268 | Jan 2013 | WO |
WO-2013019853 | Feb 2013 | WO |
WO-2013036630 | Mar 2013 | WO |
WO-2013096260 | Jun 2013 | WO |
WO-2013155117 | Oct 2013 | WO |
WO-2014099423 | Jun 2014 | WO |
WO-2015059570 | Apr 2015 | WO |
WO-2015187426 | Dec 2015 | WO |
WO-2018007914 | Jan 2018 | WO |
Entry |
---|
Extended European Search Report dated Mar. 5, 2015 in EP Patent Appl Serial No. 14189412.1. |
Gazelle et al., “Tumor Ablation with radio-frequency Energy,” Radiology, (2000), 217(3):633-646. |
Gondin, et al., Electromyostimulation training effects on neural drive and muscle architecture, Med. Sci. Sports. Exerc., 37(8):1291-9 (2005). |
Haemmerich et al., “Thermal Tumor Ablation: Devices, Clinical Applications and Future Directions,” Int. J. Hyperthermia, (2005) 21(8):775-760 (Abstract). |
Informal Response to Written Opinion dated Jan. 17, 2012 in Int'l PCT Patent Appl. Serial No. PCT/US2011/027834. |
International Search Report & Written Opinion dated Jan. 19, 2016 in Int'l PCT Patent Appl. Serial No. PCT/IB2015/055926. |
International Search Report & Written Opinion dated Mar. 19, 2015 in Int'l PCT Patent Appln Serial No. PCT/IB2014/002920. |
International Search Report & Written Opinion dated Apr. 5, 2013 in Int'l PCT Patent Application Serial No. PCT/US2012/070259. |
International Search Report and Written Opinion dated Jan. 26, 2016 in Int'l PCT Patent Appl. Serial No. PCT/IB2015/057838. |
International Search Report and Written Opinion dated Oct. 16, 2015 in Int'l PCT Patent Appl Serial No. PCT/US2015/032732. |
International Search Report dated Oct. 19, 2011 in Int'l PCT Patent Appl. Serial No. PCT/US2011/027934. |
Int'l Preliminary Report on Patentability dated May 28, 2014 in Int'l PCT Patent Appl No. PCT/US2012/070259. |
Lieber, Richard, Comparison between animal and human studies of skeletal muscle adaptation to chronic stimulation, Clinical Orthopaedics and related research, No. 233, pp. 19-24 (1988). |
Lieber, Richard, Skeletal muscle adaptability. II: Muscle properties following spinal-cord injury, Developmental medicine and Child Neurology 28(4):533-42 (1986). |
Lieber, Richard, Skeletal muscle adaptability. III: Muscle properties following chronic electrical stimulation, Developmental medicine and Child Neurology 28(5):662-70 (1986). |
Partial International Search Report dated Aug. 4, 2015 in Int'l PCT Patent Appl Serial No. PCT/US2015/032732. |
Rosatelli, et al., Three-dimensional study of the musculotendinous architecture of lumbar multifidus and its functional implications, Clinical Anatomy 21(6):539-44 (2008). |
Sippl, Charles J., “Computer Dictionary: Third Edition,” pp. 2257 and 340. |
Sluijter, “Radiofrequency Ablation in the Management of Spinal Pain,” C212, (2006), IV(1):10-15. |
Wikipedia, “Interference Fit,” http://en.wikipedia.org/wiki/Interference_fit, accessed Dec. 4, 2014. |
Wikipedia, “Time-division multiplexing,” https://en.wikipedia.org/wiki/Time-division_multiplexing (accessed Nov. 12, 2015). |
Written Opinion dated Feb. 3, 2014 in Int'l PCT Patent Appl. Serial No. PCT/US2012/070259. |
Written Opinion dated Nov. 16, 2011 in Int'l PCT Patent Appl. Serial No. PCT/US2011/027934. |
Airaksinen et al., “Chapter 4. European guidelines for the management of chronic nonspecific low back pain,” European spine journal [I: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 15 Suppl 2 (2006):S192-300. http://www.ncbi.nlm.nih.gov/pubmed/16550448. |
Baker et al., “Clinical Uses of Neuromuscular Electrical Stimulation,” NeuroMuscular Electrical Stimulation—A Practical Guide, 4th ed. Rancho Los Amimgos Research and Education Institute Inc., pp. 47-66 (2000). |
Bhadra et al., “Peripheral nerve stimulation for restoration of motor function,” Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society, 14(5):378-33 (Sep. 1997). |
Bogie et al., “Effects of regular use of neuromuscular electrical stimulation on tissue health,” Journal of Rehabilitation Research and Development, 40(6):469-475 (2003) available at: http://www.ncbi.nlm.nih.gov/pubmed/15077659 (Accessed Jan. 18, 2011). |
Bowman et al., “Effects of Waveform Parameters on Comfort during Transcutaneous Neuromuscular Electrical Stimulation,” Annals of Biomedical Engineering, 13:59-74 (1985). |
Bradford et al., “Surface Electrical Stimulation in the Treatment of Idiopathic Scoliosis: Preliminary Results in 30 Patients,” Spine, 8(7):757-764 (1983). |
Brazier et al., “A Comparison of the EQ-5D and SF-6D Across Seven Patient Groups,” Health Economics, 13:873-884 (2004). |
Coghlan et al., “Electrical muscle stimulation for deep stabilizing muscles in abdominal wall,” Conference proceedings: . . . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference, pp. 2756-2759 (2008) available at: http://www.ncbi.nlm.nih.gov/pubmed/19163276. |
Coghlan et al., “Neuromuscular electrical stimulation training results in enhanced activation of spinal stabilizing muscles during spinal loading and improvements in pain ratings,” Conference proceedings: . . . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference, pp. 7622-7625 (2011) available at: http://www.ncbi.n1m.nih.gov/pubmed/22256103. |
Crago et al., “The choice of pulse duration for chronic electrical stimulation via surface, nerve, and intramuscular electrodes,” Annals of Biomedical Engineering, 2(3):252-264 (1974). |
Criterion Inc., “NMES Treatment Protocols,” 3 pages (accessed Jun. 7, 2012) available at http://www.criterionmed.com/PDF/NMES%20Treatment%20Protocols.pdf. |
Durham et al., “Surface Electrical Stimulation Versus Brace in Treatment of Idiopathic Scoliosis,” Spine, 15(9):888-891 (1990). |
Empi, “Low Back Syndrome/Chronic Low Back Pain,” NMES Guidelines for Treatment, 2 pages (2003). |
Ferreira et al., “Comparison of general exercise, motor control exercise and spinal manipulative therapy for chronic low back pain: A randomized trial,” Pain, 131(1-2):31-37 (2007) available at: http://www.ncbi.nlm.nih.gov/pubmed/17250965. |
Freeman, et al., The Role of the Lumbar Multifidus in Chronic Low Back Pain: A Review, American Academy of Physical Medicine and Rehabilitation, 2:142-146 (2010). |
Friedman et al., “Electrical stimulation for scoliosis,” American Family Physician, 25(4):155-160 (1982) available at: http://www.ncbi.n1m.nih.gov/pubmed/6978055 (Accessed Oct. 19, 2011). |
Garmirian, et al., Discriminating Neurogenic from Myopathic Disease via Measurement of Muscle Anisotrophy, Muscle Nerve, 39(1):16-24 (2009) (Abstract only). |
Glaser et al., “Electrical Muscle Stimulation as an Adjunct to Exercise Therapy in the Treatment of Nonacute Low Back Pain: A Randomized Trial,” The Journal of Pain, 2(5):295-300 (2001). |
Gorman et al., “The effect of stimulus parameters on the recruitment characteristics of direct nerve stimulation,” IEEE Transactions on Bio-medical Engineering, 30(7):407-414 (1983). |
Hagg et al., “The Clinical Importance of Changes in Outcome Scores After Treatment for Chronic Low Back Pain,” Eur. Spine. J., 12:12-20 (2003). |
Herbert et al., “Scoliosis Treatment in Children Using a Programmable, Totally Implantable Muscle Stimulator (ESI),” IEEE Transactions on Biomedical Engineering, 36(7):801 (Jul. 1989). |
Hodges et al., “Response of the deep paraspinal muscles to cortical but not transmastoid stimulation is increased at a single lumbar level following interverebral disc lesion,” Progress in Motor Control Vi—Brazil. 36:2-3 (2007). |
Hodges, et al., Intervetebral Stiffness of the Spine is Increased by Evoked Contraction of Transversus Abdominis and the Diaphragm: In Vivo Porcine Studies, Spine 28(23):2594-2601 (2003) (Abstract only). |
Hodges, Is There a Role for Transversus Abdominis in Lumbo-Pelvis Stability? Manual Therapy, 4(2):74-86 (1999). |
Holm, et al., Sensorimotor Control of the Spine, J. Electromyogr. Kinesiol. 12(3):219-34 (2002) (Abstract only). |
Hortobagyi et al., “Neural adaptations to electrical stimulation strength training,” European Journal of Applied Physiology, 2439-2449 (2011) available at: http://www.ncbi.nlm.nih.gov/pubmed/21643920 (Accessed Jul. 19, 2011). |
Keller, et al., Muscular Contributions to Dynamic Dorsoventral Lumber Spine Stiffness, Eur. Spine J., 16(2):245-54 (2007). |
Kiesel et al., “Measurement of lumbar multifidus muscle contraction with rehabilitative ultrasound imaging,” Manual Therapy, 12(2):161-166 (2007) available at: http://www.ncbi.nlm.nih.gov/pubmed/16973400. |
Lauridsen et al., “Responsiveness and Minimal Clinically Important Difference for Pain and Disability Instruments in Low Back Pain Patients,” BMC Musculoskeletal Disorders, 7(82):16 pages (2006). |
Miyatani, et al., Validity of Estimating Limb Muscle Volume By Bioelectrical Impedance, J. Appl. Physiol., 91:386-394 (2001). |
Mortimer et al., “Intramuscular electrical stimulation: tissue damage,” Annals of Biomedical Engineering, 8(3):235-244 (1980). |
Mortimer et al., “Peripheral Nerve and Muscle Stimulation. In: Horch KW, Dhillon G, eds,” Neuroprosthetics: Theory and Practice (Series on Bioengineering & Biomedical Engineering—vol. (2), World Scientific Publishing Company, pp. 1-48 (2005). |
Nachemson et al., “Effectiveness of Treatment with a Brace in Girls Who Have Adolescent Idiopathic Scoliosis,” The Journal of Bone and Joint Surgery, 77-A(6):815-819 (Jun. 1995). |
Oaao Bock, “ActiGait Implantable Drop Foot Stimulator,” Surgeon Manual, 28 pages (2006). |
O'Donnell et al., “Electrical Stimulation in the Treatment of Idiopathic Scoliosis,” Clinical Orthopaedics and Related Research, No. 229:107-112 (Apr. 1988). |
Paicius et al., “Peripheral Nerve Field Stimulation for the Treatment of Chronic Low Back Pain: Preliminary Results of Long-Term Follow-up: A Case Series,” Neuromodulation, 10(3):279-290 (2007) available at: http://www.blackwell-synergy.com/doi/abs/l0.llll/j.1525-1403.2007.00116.x. |
Panjabi, Manohar, “A hypothesis of chronic back pain: ligament subfailure injuries lead to muscle control dysfunction,” European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 15, No. 5 (May 2006): 668-676. http://www.ncbi.nlm.nih.gov/pubmed/16047209. |
Panjabi, Manohar, “The stabilizing system of the spine. Part 1. Function, dysfunction, adaptation, and enhancement,” Journal of Spinal Disorders, 5(4)383-389 (Dec. 1992), Discussion 397. http://www.ncbi.nlm.nih.gov/pubmed/1490034. |
Panjabi, Manohar, “The stabilizing system of the spine. Part II. Neutral zone and instability hypothesis,” Journal of Spinal Disorders, 5(4):390-396 (Dec. 1992), Discussion 397. http://www.ncbi.nlm.nih.gov/pubmed/1490035. |
PCT International Search Report and Written Opinion dated Sep. 3, 2013 in related PCT Application No. PCT/US2013/045223. |
Peckham et al., “Functional electrical stimulation for neuromuscular applications,” Annual review of Biomedical Engineering, 7:327-360 (2005) available at: http://www.ncbi.nlm.nih.gov/pubmed/16004574. |
Peterson et al., “Long-term intramuscular electrical activation of the phrenic nerve: safety and reliability,” IEEE Transactions on Bio-medical Engineering, 41(12):1115-1126 (1994). |
Poitras et al., “Evidence-informed management of chronic low back pain with transcutaneous electrical nerve stimulation, interferential current, electrical muscle stimulation, ultrasound, and thermotherapy,” The Spine Journal 8:226-233 (2008). |
Reed B., :The Physiology of Neuromuscular Electrical Stimulation, Pediatric Physical Therapy, 9(3):96-102 (1997) available at: http://journals.lww.com/pedpt/pages/artic1eviewer.aspx?year=1997&issue=00930&article=00002&type=abstract. |
RS Medical, “RS-4M Muscle Stimulator,” available at http://www.rsmedical.com/documents/fact_sheet_RS4m.pdf (last visited Jul. 19, 2012). |
Rutkove, “Electrical Impedance Myography: Background, Current State, and Future Directions,” Muscle Nerve, 40(6):936-946 (2009). |
Schwartz et al., “Therapeutic Electrical Stimulation of the Hypoglossal Nerve in Obstructive Sleep Apnea,” Arch Otolaryngal Head Neck Surg., 127:1216-1223 (2001). |
Sheffler et al., “Neuromuscular Electrical Stimulation in Neurorehabilitation,” Muscle Nerve, 35: 562-590 (2007). |
Solomonow et al., “The Ligamento-Muscular Stabilizing System of the Spine,” Spine, (1998), 23(23):2552-2562. |
Spinal Fusion Guidelines, MD Guidelines, 2009. www.mdguidelines.com/spinal-fusion. |
Stokes, et al., “Surface EMG Electrodes Do Not Accurately Record from Lumbar Multifidus Muscles,” Clin. Biomech, (2003), 18(1):9-13 (Abstract Only). |
Van Dieen, et al., “Trunk Muscle Recruitment Patterns,” Spine, (2003), 28(8):834-841 (Abstract Only). |
Van et al., “The use of real-time ultrasound imaging for biofeedback of lumbar multifidus muscle contraction in healthy subjects,” The Journal of Orthopaedic and Sports Physical Therapy, 36(12):920-925 (2006) available at: http://www.ncbi.n1m.nih.gov/pubmed/17193869. |
Van Zundert et al., “Radiofrequency treatment for chronic pain syndromes,” CPD Anaesthesis, 6(1):13-17 (2004). |
Verrills et al., “Peripheral Nerve Stimulation: A Treatment for Chronic Low Back Pain and Failed Back Surgery Syndrome?,” Neuromodulation: Technology at the Neural Interface, (2009), 12(1):68-75. |
Vrbova et al., Application of Muscle/Nerve Stimulation in Health and Disease, Springer Verlag (2008) available at: http://books.google.com/books?hl=en&1r=&id=jb8fDGxkbqEC&oi=fnd&pg=PAI&dq=Application of Muscle/Nerve Stimulation in Health and Disease&ots=CMV5rXiDQD&sig=Wg8u1YOC4PgvVDzcjdwBub5U2To (Accessed Jun. 2, 2011). |
Wallwork et al., “The effect of chronic low back pain on size and contraction of the lumbar multifidus muscle,” Manual Therapy, 14(5):496-500 (2009) available at: http://www.ncbi.nlm.nih.gov/pubmed/19027343. |
Ward et al., “Architectural analysis and intraoperative measurements demonstrate the unique design of the multifidus for lumbar spine stability,” J. Bone Joint Surg. [Am.] 91:176-185, PMC2663324 (2009). |
Wright et al., “Morphologic and histochemical characteristics of skeletal muscle after long-term intramuscular electrical stimulation,” Spine, 17(7):767-770 (1992) available at: http://www.ncbi.nlm.nih.gov/pubmed/1502640 (Accessed Aug. 2, 2011). |
U.S. Appl. No. 15/202,435, filed Jul. 5, 2016, Beck et al. |
U.S. Appl. No. 15/202,485, filed Jul. 5, 2016, Beck et al. |
Medtronic Extension Passer 3555 Accessory Kit—Technical Instructions, 2 pages (2001). |
Medtronic Interstim Therapy 3093 & 3889—Implant Manual, 38 pages (2010). |
Medtronic Model 3464 Receiver/Extension Internalization Manual, SE-4 for Spinal Cord Stimulation (SCS), 7 pages (1986). |
Deckers, et al., Chronic Low Back Pain: Restoration of Dynamic Stability, Neuromodulation, 18:478-486 (2015). |
International Search Report & Written Opinion dated Sep. 28, 2017 in Int'l PCT Patent Appl. Serial No. PCT/IB2017/053945. |
International Search Report & Written Opinion dated Oct. 20, 2017 in Int'l PCT Patent Appl. Serial No. PCT/IB2017/053946. |
MicroProbes for Life Science, Nerve Cuff electrodes,2018, available at https://microprobes.com/products/peripheral-electrodes/nerve-cuff, accessed Mar. 5, 2018. |
Unit III—The Spine, “Motions of the Spine,” available at https://courses.vcu.edu/DANC291-003/unit_3.htm, accessed Mar. 5, 2018. |
U.S. Appl. No. 12/075,174, filed Mar. 10, 2008, now U.S. Patent No. 8,428,728 dated Apr. 23, 2013. |
U.S. Appl. No. 13/045,421, filed Mar. 10, 2011, now U.S. Patent No. 9,248,278 dated Feb. 2, 2016. |
U.S. Appl. No. 13/045,435, filed Mar. 10, 2011. |
U.S. Appl. No. 13/564,584, filed Aug, 1, 2012, now U.S. Patent No. 9,079,019 dated Jul. 14, 2015. |
U.S. Appl. No. 13/718,806, filed Dec. 18, 2012, now U.S. Patent No. 9,108,053 dated Aug. 18, 2015. |
U.S. Appl. No. 13/797,100, filed Mar. 12, 2013. |
U.S. Appl. No. 13/858,809, filed Apr. 8, 2013, now U.S. Patent No. 8,606,358 dated Dec. 10, 2013. |
U.S. Appl No. 14/061,614, filed Oct. 23, 2013, now U.S. Patent No. 9,072,897 dated Jul. 7, 2015. |
U.S. Appl. No. 14/295,153, filed Jun. 30, 2014, now U.S. Patent No. 9,186,153 dated Nov. 17, 2015. |
U.S. Appl. No. 14/792,430, filed Jul. 6, 2015. |
U.S. Appl. No. 14/849,478, filed Sep. 9, 2015. |
U.S. Appl. No. 14/882,087, filed Oct. 13, 2015. |
U.S. Appl. No. 14/939,955, filed Nov. 12, 2015. |
U.S. Appl. No. 15/202,435, filed Jul. 5, 2016. |
U.S. Appl. No. 15/202,485, filed Jul. 5, 2016. |
Number | Date | Country | |
---|---|---|---|
20140350653 A1 | Nov 2014 | US |
Number | Date | Country | |
---|---|---|---|
61659334 | Jun 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14061614 | Oct 2013 | US |
Child | 14453423 | US | |
Parent | 13797100 | Mar 2013 | US |
Child | 14061614 | US |